Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Hilton Grand Vacations
HGV
$3.53B
| $2.67M | 0.01% |
71,484
-209,816
| -75% | -$8.37M |
|
1152
Amer Sports
AS
$18.2B
| $2.67M | 0.01% |
99,827
-11,391
| -10% | -$337K |
|
|
UCB
1153
United Community Banks
UCB
$4.27B
| $2.66M | 0.01% |
+94,683
| New | +$2.96M |
|
1154
CALL
Polaris
PII
$3.66B
| $2.66M | 0.01% |
65,000
+32,000
| +97% | +$1.52M |
|
|
GRSD
1155
Grandstand Ltd
GRSD
$70.8M
| $2.66M | 0.01% |
210,429
+98,244
| +88% | +$1.38M |
|
1156
CALL
Duke Energy
DUK
$95.1B
| $2.65M | 0.01% |
21,700
+17,300
| +393% | +$1.97M |
|
1157
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.29B
| $2.64M | 0.01% |
11,874
-787
| -6% | -$194K |
|
1158
Exelixis
EXEL
$13.5B
| $2.62M | 0.01% |
71,077
-11,050
| -13% | -$394K |
|
1159
Avis
CAR
$5.19B
| $2.6M | 0.01% |
34,278
-18,317
| -35% | -$1.47M |
|
1160
Travel + Leisure Co
TNL
$4.48B
| $2.6M | 0.01% |
+56,162
| New | +$2.95M |
|
1161
JB Hunt Transport Services
JBHT
$24.4B
| $2.6M | 0.01% |
+17,546
| New | +$2.89M |
|
1162
Peabody Energy
BTU
$3.4B
| $2.59M | 0.01% |
191,449
+166,685
| +673% | +$2.68M |
|
1163
AstraZeneca
AZN
$259B
| $2.59M | 0.01% |
17,638
+1,588
| +10% | +$230K |
|
1164
CALL
Boston Scientific
BSX
$71B
| $2.59M | 0.01% |
25,700
+21,100
| +459% | +$2.12M |
|
1165
Lifeway Foods
LWAY
$398M
| $2.59M | 0.01% |
106,000
+71,000
| +203% | +$1.6M |
|
1166
UWM Holdings
UWMC
$2.28B
| $2.58M | 0.01% |
472,747
+231,346
| +96% | +$1.41M |
|
1167
PUT
Nabors Industries
NBR
$1.31B
| $2.58M | 0.01% |
61,800
+5,800
| +10% | +$295K |
|
1168
Franklin Templeton
BEN
$17.6B
| $2.57M | 0.01% |
133,501
-149,452
| -53% | -$2.99M |
|
1169
EnerSys
ENS
$6.76B
| $2.57M | 0.01% |
+28,055
| New | +$2.74M |
|
1170
Preferred Bank
PFBC
$1.23B
| $2.57M | 0.01% |
30,705
+23,981
| +357% | +$2.08M |
|
1171
Aspen Aerogels
ASPN
$416M
| $2.57M | 0.01% |
401,667
+300,188
| +296% | +$2.89M |
|
1172
Kilroy Realty
KRC
$4.29B
| $2.57M | 0.01% |
78,344
+57,802
| +281% | +$2.07M |
|
1173
Eastman Chemical
EMN
$8.31B
| $2.57M | 0.01% |
+29,123
| New | +$2.75M |
|
|
NAGE
1174
Niagen Bioscience
NAGE
$254M
| $2.57M | 0.01% |
371,798
+154,230
| +71% | +$969K |
|
1175
CALL
monday.com
MNDY
$3.98B
| $2.55M | 0.01% |
+10,500
| New | +$2.77M |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.